https://www.avient.com/company/sustainability/performance/eps-expansion
And combined efforts to execute our strategy have worked. 2018 marked the ninth consecutive year of adjusted EPS expansion at Avient, as we delivered $2.43 per share.
Over this period, we have significantly increased our operating margins in each of our businesses, as well as our Return on Invested Capital, and we have raised our dividend for seven years in a row.
As a result, we’ve generated $1.3 billion dollars in revenue from sustainable solutions over the last three years.
https://www.avient.com/investors/stock-information/investor-faq
Avient’s annual dividend is $1.08 per share, paid in quarterly increments of $0.27 per share.
When is Avient’s fiscal year end?
Avient’s fiscal year ends on December 31st.
https://www.avient.com/news/polyone-announces-20-increase-quarterly-dividend
CLEVELAND – Oct. 8, 2015 – The Board of Directors of PolyOne Corporation (NYSE: POL) has declared a quarterly cash dividend of twelve cents ($0.12) per share on the common stock outstanding, representing a 20% increase to the quarterly cash dividend and the fifth consecutive year of annual dividend growth.
The $0.12 per share will be paid on January 7, 2016 to stockholders of record on December 18, 2015.
I am pleased to announce an increase in our quarterly dividend, which now represents the fifth consecutive year of annual dividend growth,” said Robert M.
https://www.avient.com/sites/default/files/resources/Application%2520Bulletin%2520Resilience%2520HC.pdf
Public Health Service, the incidence of hospital-acquired infections (HAI’s), such as MRSA and VRE, has increased approximately 36% in the last 20 years and today causes nearly 100,000 deaths annually.
Because insurance companies and Medicare will no longer reimburse the costs associated with HAI’s, the financial burden, estimated at $14,000 per infection, falls on the patient or hospital.
https://www.avient.com/investor-center/news/avient-announces-first-quarter-2023-results
Full year adjusted EBITDA and EPS guidance of
Second Quarter and Full Year 2023 Outlook
Cash and cash equivalents at beginning of year
https://www.avient.com/full-year-2024-results
Avient reported strong Q4 and full year 2024 results.
Q4 sales grew to $747 million, up 5% organically over the prior year (excluding the impact of foreign exchange).
Full year sales grew to $3.24 billion, up 4% organically compared to 2023.
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2024-results
In millions, except per share data)
In millions, except per share data)
In millions, except per share data)
https://www.avient.com/investor-center/investor-news/archives?page=34
Adjusted earnings per share increases 22% to $0.56; GAAP EPS improves 35% to $0.46 versus $0.34 in the prior year
- Achieves 26th consecutive qua
https://www.avient.com/investor-center/investor-news/archives?page=32
Reports GAAP earnings per share of $0.59 vs. $0.74 in the prior year, reflecting the favorable impact of certain tax benefits recognized in 2015
https://www.avient.com/investor-center/news/avient-announces-record-third-quarter-2021-results
in the prior year third quarter.
Earnings per share attributable to
Year Ended